Supply of blood-derived medicinal products 2027

Summary

The Nice University Hospital group is procuring blood-derived medicinal products for hospitals in Antibes, Cannes, Grasse, Menton and Nice in 16 lots. The procurement is structured as a framework agreement starting on 1 March 2027 for one year, with three possible one-year renewals, and ending no later than 28 February 2031. The overall maximum value is €166,000,000 excluding VAT; the estimated value is €132,655,777. Lot 12 is a multi-supplier lot, with the called-off quantities allocated 60%, 35% and 5% among three suppliers.